Sensorion SA

NEW
FRA:RFM (France)  
€ 0.24 +0.0060 (+2.61%) Jul 3
At Loss
P/B:
1.76
Market Cap:
€ 133.94M ($ 153.22M)
Enterprise V:
€ 87.76M ($ 100.39M)
Volume:
0
Avg Vol (2M):
42.58K
Trade In:

Business Description

Description
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
Name Current Vs Industry Vs History
Cash-To-Debt
37.05
Equity-to-Asset
0.77
Debt-to-Equity
0.03
Debt-to-EBITDA
-0.05
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
74.15
9-Day RSI
53.65
14-Day RSI
44.98
3-1 Month Momentum %
-3.42
6-1 Month Momentum %
28.45
12-1 Month Momentum %
39.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
4.59
Quick Ratio
4.59
Cash Ratio
3.97

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-55.6
Shareholder Yield %
0.53

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-50.86
ROA %
-40.04
ROIC %
-335.57
3-Year ROIIC %
490.33
ROC (Joel Greenblatt) %
-1258.86
ROCE %
-48.52

Financials

FRA:RFM's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Sensorion SA Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.1
Beta -1.4433
3-Year Sharpe Ratio 0.23
3-Year Sortino Ratio 0.56
Volatility % 61.41
14-Day RSI 44.98
14-Day ATR (€) 0.013778
20-Day SMA (€) 0.228095
12-1 Month Momentum % 39.23
52-Week Range (€) 0.1902 - 0.65
Shares Outstanding (Mil) 515.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sensorion SA Filings

Filing Date Document Date Form
No Filing Data

Sensorion SA Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Sensorion SA Frequently Asked Questions

What is Sensorion SA(FRA:RFM)'s stock price today?
The current price of FRA:RFM is €0.24. The 52 week high of FRA:RFM is €0.65 and 52 week low is €0.19.
When is next earnings date of Sensorion SA(FRA:RFM)?
The next earnings date of Sensorion SA(FRA:RFM) is .
Does Sensorion SA(FRA:RFM) pay dividends? If so, how much?
Sensorion SA(FRA:RFM) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Sensorion SA

No articles.